首页> 美国政府科技报告 >Persistence of Human Antibody to Venezuelan Equine Encephalomyelitis (VEE) Virus Subtypes after Immunization with Attenuated (TC-83) VEE Vaccine.
【24h】

Persistence of Human Antibody to Venezuelan Equine Encephalomyelitis (VEE) Virus Subtypes after Immunization with Attenuated (TC-83) VEE Vaccine.

机译:用减毒(TC-83)VEE疫苗免疫后委内瑞拉马脑脊髓炎(VEE)病毒亚型的人抗体持续存在。

获取原文

摘要

The persistence of serum antibody of Venezuelan equine encephalomyelitis (VEE) virus subtypes was studied in 20 volunteers inoculated 7 or 9 years previously with attenuated TC-83 VEE vaccine. Serological patterns were compared with those of 10 other persons bled 28 days after vaccination with TC-83. Vaccinees had no other known group A arbovirus exposure. Neutralizing antibody titers of > 1:10 were measured against the homologous TC-83 virus strain in all long- and short-term vaccinees. In both groups of vaccinees the percentage of antibody-positive persons and their geometric mean titers were higher against the epizootic subtypes I-A, I-B, I-C, than against the enzootic subtypes, I-D, I-E, II, III, and IV. However proportionally fewer long-term vaccinees than short-term vaccinees, had detectable neutralizing antibody reactive with enzootic strains. These results reveal long-lasting circulation of neutralizing antibody to TC-83 virus and closely related epizootic variants in 95-100% of vaccinees. The relatively lower antibody conversion rate and loss of antibody to more antigenically remote enzootic VEE subtypes suggests that vaccinees may be less well protected against infection by these strains.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号